Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis. [PDF]
Lu X, Zhang Y, Zhang H, Tang K, Jin H.
europepmc +1 more source
Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series. [PDF]
Tejero-García C +15 more
europepmc +1 more source
Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report. [PDF]
Medina-Figueroa MD +4 more
europepmc +1 more source
Successful management of DPP-4 inhibitor-induced bullous pemphigoid with Stapokibart injection in an elderly diabetic patient: a case report. [PDF]
Yu M, Tian S, Meng F.
europepmc +1 more source
The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience. [PDF]
Massi A +11 more
europepmc +1 more source
Localized Bullous Pemphigoid Triggered by Surgical Trauma: A Case Highlighting the Koebner Phenomenon. [PDF]
Faik Ouahab M, Chiheb S, Kelati A.
europepmc +1 more source
The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response. [PDF]
Mansini AP +10 more
europepmc +1 more source
Localized bullous pemphigoid masquerading as venous leg ulcers in a patient with chronic venous insufficiency. [PDF]
Perry A, Namazian S, Vu T, Mervis J.
europepmc +1 more source
Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation. [PDF]
Chiang YL +5 more
europepmc +1 more source

